5 February 2012 - Rhenovia Pharma opens first US office
Rhenovia Pharma Expands activities to the Greater Boston Area
Deployment will widen use of biosimulation technology
Mulhouse, France and Cambridge, Massachusetts, USA, January 25, 2012 - Rhenovia Pharma SAS, a biotechnology company specializing in biosimulation applied to the discovery of new medications to treat brain diseases such as Alzheimer's, today announces its first international subsidiary, Rhenovia Inc., incorporated in Delaware.
